14th March
TriviumVet’s felycin®-CA1 has been granted conditional approval by the U.S. Food and Drug Administration (FDA). This marks a significant milestone in feline cardiac care as the...
RAPACAT HCM trial results unveiled at International Cardio-Renal Veterinary Symposium (ICVS) 2022
1st October
Feline hypertrophic cardiomyopathy remains the greatest unmet need in veterinary cardiology, affecting around 15% of all pet cats. After two years of collaboration between...
TriviumVet to exhibit at VMX 2023. TriviumVet will be participating in the New Exhibitors Area – Zone A – Booth 5203
19th September
TriviumVet to exhibit at VMX 2023 in Orlando Florida Veterinary professionals worldwide are set to learn the latest in veterinary medicine at VMX 2023. The North American...
A great summary by FDA's Dr. Christopher Loss on Conditionally Approved Animal Drugs and what it means to use them
6th September
Abstract The purpose of this article is to provide veterinarians with an understanding of what it means to use a conditionally approved drug. This article summarizes information...
Esteemed veterinary cardiologist and researcher Dr. Joshua Stern appointed to the TriviumVet Scientific Advisory Board
26th August
Esteemed veterinary cardiologist and researcher Dr. Joshua Stern appointed to the TriviumVet Scientific Advisory Board. TriviumVet™, an animal health research and development...
TriviumVet work with The Ohio State University evaluating the benefit of Rapamycin in cats.
15th April
We are delighted to be working with The Ohio State University on an exciting clinical trial evaluating the benefit a new drug in cats with chronic kidney disease. Details of the...
TriviumVet support UC Davis and the Morris Animal Foundation in a novel research.
11th April
We are excited to support UC Davis and the Morris Animal Foundation in a novel research. Subvalvular aortic stenosis (SAS) is a common heart defect in dogs which often leads to...
A great catch up with our colleagues in the US.
11th March
Our CTO Stuart Fitzgerald and Regulatory Affairs Manager Susan Kennedy had a successful trip to the US where they got to connect and catch up with thought leaders in veterinary...
CEO Louise Grubb won Entrepreneur of The Year at the 2021 Waterford Business Awards.
9th March
A great celebration for our female led company as our CEO Louise Grubb has won Entrepreneur of The Year at the 2021 Waterford Business Awards. Louise Grubb, founder and CEO of...
TriviumVet represented at the VMX Conference presented by North American Veterinary Community
1st February
It was great to have TriviumVet represented by our CEO Louise Grubb and CTO Stuart Fitzgerald at a very informative VMX conference presented by North American Veterinary Community...
Recent visit with our Researchers at North Carolina State University College of Veterinary Medicine.
31st January
Our CEO Louise Grubb and CTO Stuart Fitzgerald were delighted to catch up with Dean Kate Meurs and many of our wonderful researchers at North Carolina State University College of...
TriviumVet to exhibit at VMX 2023. TriviumVet will be participating in the New Exhibitors Area – Zone A – Booth 5203
19th September
TriviumVet to exhibit at VMX 2023 in Orlando Florida Veterinary professionals worldwide are set to learn the latest in veterinary medicine at VMX 2023. The North American...
A great summary by FDA's Dr. Christopher Loss on Conditionally Approved Animal Drugs and what it means to use them
6th September
Abstract The purpose of this article is to provide veterinarians with an understanding of what it means to use a conditionally approved drug. This article summarizes information...
Esteemed veterinary cardiologist and researcher Dr. Joshua Stern appointed to the TriviumVet Scientific Advisory Board
26th August
Esteemed veterinary cardiologist and researcher Dr. Joshua Stern appointed to the TriviumVet Scientific Advisory Board. TriviumVet™, an animal health research and development...
TriviumVet work with The Ohio State University evaluating the benefit of Rapamycin in cats.
15th April
We are delighted to be working with The Ohio State University on an exciting clinical trial evaluating the benefit a new drug in cats with chronic kidney disease. Details of the...
TriviumVet support UC Davis and the Morris Animal Foundation in a novel research.
11th April
We are excited to support UC Davis and the Morris Animal Foundation in a novel research. Subvalvular aortic stenosis (SAS) is a common heart defect in dogs which often leads to...
A great catch up with our colleagues in the US.
11th March
Our CTO Stuart Fitzgerald and Regulatory Affairs Manager Susan Kennedy had a successful trip to the US where they got to connect and catch up with thought leaders in veterinary...
CEO Louise Grubb won Entrepreneur of The Year at the 2021 Waterford Business Awards.
9th March
A great celebration for our female led company as our CEO Louise Grubb has won Entrepreneur of The Year at the 2021 Waterford Business Awards. Louise Grubb, founder and CEO of...
TriviumVet represented at the VMX Conference presented by North American Veterinary Community
1st February
It was great to have TriviumVet represented by our CEO Louise Grubb and CTO Stuart Fitzgerald at a very informative VMX conference presented by North American Veterinary Community...
Recent visit with our Researchers at North Carolina State University College of Veterinary Medicine.
31st January
Our CEO Louise Grubb and CTO Stuart Fitzgerald were delighted to catch up with Dean Kate Meurs and many of our wonderful researchers at North Carolina State University College of...